SCHEMBL7850415

SCHEMBL7850415

CCCCC1(CCCC)[C@H](O)[C@H](c2ccc(O)cc2)c2cc(N(C)C)ccc2S(=O)(=O)N1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7853297 0.85 SLC10A2 (1.00) SLC10A2
SCHEMBL7849977 0.82 SLC10A2 (1.00) SLC10A2
SCHEMBL6222440 0.79 SLC10A2 (1.00) SLC10A2
SCHEMBL18176640 0.79 SLC10A2 (1.00) SLC10A2
SCHEMBL7655202 0.78 SLC10A2 (0.64) SLC10A2
Hydrochloric Acid SCHEMBL7675400 0.78 SLC10A2 (1.00) SLC10A2
SCHEMBL7852691 0.77 SLC10A2 (1.00) SLC10A2
SCHEMBL6222443 0.76 SLC10A2 (0.80) SLC10A2
SCHEMBL21594693 0.73 SLC10A2 (0.72) SLC10A2
SCHEMBL21085478 0.73 SLC10A2 (0.72) SLC10A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 EP disclosed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 WO disclosed